Read + Share
Amedeo Smart
Independent Medical Education
Hansen MK, Olesen KKW, Gyldenkerne C, Thrane PG, et al. Eligibility for and Preventive Potential of Semaglutide in Overweight and Obese Patients With Myocardial Infarction. J Am Coll Cardiol 2024;83:956-958.PMID: 38418010
Email
LinkedIn
Facebook
Twitter
Privacy Policy